vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and LTC PROPERTIES INC (LTC). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $84.3M, roughly 2.0× LTC PROPERTIES INC). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 60.3%). Over the past eight quarters, LTC PROPERTIES INC's revenue compounded faster (28.1% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

LTC Properties Inc is a U.S.-based real estate investment trust (REIT) that owns, finances, and manages seniors housing and healthcare-related real estate assets. Its core portfolio includes assisted living facilities, skilled nursing properties, memory care centers, and independent living communities for senior care and healthcare service operators.

ESPR vs LTC — Head-to-Head

Bigger by revenue
ESPR
ESPR
2.0× larger
ESPR
$168.4M
$84.3M
LTC
Growing faster (revenue YoY)
ESPR
ESPR
+83.4% gap
ESPR
143.7%
60.3%
LTC
Faster 2-yr revenue CAGR
LTC
LTC
Annualised
LTC
28.1%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
LTC
LTC
Revenue
$168.4M
$84.3M
Net Profit
$103.7M
Gross Margin
Operating Margin
50.6%
Net Margin
123.0%
Revenue YoY
143.7%
60.3%
Net Profit YoY
429.1%
EPS (diluted)
$0.32
$2.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
LTC
LTC
Q4 25
$168.4M
$84.3M
Q3 25
$87.3M
$69.3M
Q2 25
$82.4M
$60.2M
Q1 25
$65.0M
$49.0M
Q4 24
$69.1M
$52.6M
Q3 24
$51.6M
$55.8M
Q2 24
$73.8M
$50.1M
Q1 24
$137.7M
$51.4M
Net Profit
ESPR
ESPR
LTC
LTC
Q4 25
$103.7M
Q3 25
$-31.3M
$-20.0M
Q2 25
$-12.7M
$15.1M
Q1 25
$-40.5M
$20.7M
Q4 24
$19.6M
Q3 24
$-29.5M
$29.4M
Q2 24
$-61.9M
$19.4M
Q1 24
$61.0M
$24.2M
Operating Margin
ESPR
ESPR
LTC
LTC
Q4 25
50.6%
Q3 25
-11.4%
71.9%
Q2 25
8.6%
80.5%
Q1 25
-34.0%
37.8%
Q4 24
-6.4%
Q3 24
-31.0%
95.5%
Q2 24
3.5%
38.0%
Q1 24
52.5%
47.3%
Net Margin
ESPR
ESPR
LTC
LTC
Q4 25
123.0%
Q3 25
-35.9%
-28.9%
Q2 25
-15.4%
25.1%
Q1 25
-62.2%
42.2%
Q4 24
37.3%
Q3 24
-57.2%
52.6%
Q2 24
-83.9%
38.6%
Q1 24
44.3%
47.2%
EPS (diluted)
ESPR
ESPR
LTC
LTC
Q4 25
$0.32
$2.19
Q3 25
$-0.16
$-0.44
Q2 25
$-0.06
$0.32
Q1 25
$-0.21
$0.45
Q4 24
$-0.14
$0.38
Q3 24
$-0.15
$0.66
Q2 24
$-0.33
$0.44
Q1 24
$0.34
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
LTC
LTC
Cash + ST InvestmentsLiquidity on hand
$167.9M
$14.4M
Total DebtLower is stronger
$842.2M
Stockholders' EquityBook value
$-302.0M
$1.1B
Total Assets
$465.9M
$2.1B
Debt / EquityLower = less leverage
0.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
LTC
LTC
Q4 25
$167.9M
$14.4M
Q3 25
$92.4M
$17.9M
Q2 25
$86.1M
$7.6M
Q1 25
$114.6M
$23.3M
Q4 24
$144.8M
$9.4M
Q3 24
$144.7M
$35.0M
Q2 24
$189.3M
$6.2M
Q1 24
$226.6M
$9.0M
Total Debt
ESPR
ESPR
LTC
LTC
Q4 25
$842.2M
Q3 25
$944.5M
Q2 25
$696.5M
Q1 25
$682.2M
Q4 24
$684.6M
Q3 24
$785.3M
Q2 24
$861.0M
Q1 24
$860.2M
Stockholders' Equity
ESPR
ESPR
LTC
LTC
Q4 25
$-302.0M
$1.1B
Q3 25
$-451.4M
$957.9M
Q2 25
$-433.5M
$957.5M
Q1 25
$-426.2M
$961.9M
Q4 24
$-388.7M
$960.6M
Q3 24
$-370.2M
$947.8M
Q2 24
$-344.2M
$889.1M
Q1 24
$-294.3M
$886.2M
Total Assets
ESPR
ESPR
LTC
LTC
Q4 25
$465.9M
$2.1B
Q3 25
$364.0M
$2.0B
Q2 25
$347.1M
$1.8B
Q1 25
$324.0M
$1.8B
Q4 24
$343.8M
$1.8B
Q3 24
$314.1M
$1.9B
Q2 24
$352.3M
$1.9B
Q1 24
$373.1M
$1.8B
Debt / Equity
ESPR
ESPR
LTC
LTC
Q4 25
0.78×
Q3 25
0.99×
Q2 25
0.73×
Q1 25
0.71×
Q4 24
0.71×
Q3 24
0.83×
Q2 24
0.97×
Q1 24
0.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
LTC
LTC
Operating Cash FlowLast quarter
$45.2M
$136.0M
Free Cash FlowOCF − Capex
$128.7M
FCF MarginFCF / Revenue
152.7%
Capex IntensityCapex / Revenue
0.0%
8.6%
Cash ConversionOCF / Net Profit
1.31×
TTM Free Cash FlowTrailing 4 quarters
$220.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
LTC
LTC
Q4 25
$45.2M
$136.0M
Q3 25
$-4.3M
$38.4M
Q2 25
$-31.4M
$30.0M
Q1 25
$-22.6M
$29.6M
Q4 24
$-35.0M
$125.9M
Q3 24
$-35.3M
$34.0M
Q2 24
$-7.2M
$37.0M
Q1 24
$53.8M
$21.1M
Free Cash Flow
ESPR
ESPR
LTC
LTC
Q4 25
$128.7M
Q3 25
$34.3M
Q2 25
$28.9M
Q1 25
$28.2M
Q4 24
$112.2M
Q3 24
$-35.5M
$27.7M
Q2 24
$-7.3M
$34.7M
Q1 24
$53.8M
$19.7M
FCF Margin
ESPR
ESPR
LTC
LTC
Q4 25
152.7%
Q3 25
49.4%
Q2 25
47.9%
Q1 25
57.6%
Q4 24
213.4%
Q3 24
-68.7%
49.7%
Q2 24
-9.9%
69.1%
Q1 24
39.0%
38.4%
Capex Intensity
ESPR
ESPR
LTC
LTC
Q4 25
0.0%
8.6%
Q3 25
0.0%
6.0%
Q2 25
0.0%
1.9%
Q1 25
0.0%
2.7%
Q4 24
0.0%
26.0%
Q3 24
0.3%
11.2%
Q2 24
0.1%
4.6%
Q1 24
0.1%
2.6%
Cash Conversion
ESPR
ESPR
LTC
LTC
Q4 25
1.31×
Q3 25
Q2 25
1.99×
Q1 25
1.43×
Q4 24
6.43×
Q3 24
1.16×
Q2 24
1.91×
Q1 24
0.88×
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

LTC
LTC

Seniors Housing Operating Portfolio Segment$72.1M86%
Other$12.2M14%

Related Comparisons